A new study sheds light on how autophagy, the body’s process for removing damaged cell parts, when impaired, can play a role in causing heart failure. The research team identified a signaling pathway that links autophagy to the control of cellular levels of a key coenzyme known as NAD+, which is found in all living cells and is central to how our metabolism works. Researchers say these findings may have implications for heart failure treatment.
“Heart failure remains a leading cause of mortality and there is a strong need to develop new therapies that can improve cardiac function and increase survival. The identification of a new pathway linking impaired autophagy, a characteristic of heart failure, and increased NAD+ breakdown could open new avenues for therapeutic intervention,” the author said.
Autophagy is a natural, self-serving mechanism in which the body removes damaged or dysfunctional parts of a cell and recycles their components toward cellular repair or energy production. The author describes it as our body's cellular recycling system that allows cells to break down bad parts of itself and salvage some of those parts to repurpose into new, usable parts. Given the important role of autophagy in cell breakdown and repair, impaired autophagy is known to cause a range of disorders, including cancer, neurodegeneration and heart failure.
Until now, however, scientists weren't sure what mechanisms underlie mitochondrial and cardiac dysfunction in the setting of impaired autophagy. One proposed mechanism has been the build-up of dysfunctional mitochondria that takes place when autophagy is impaired, as this build-up can activate inflammatory and other responses that can lead to cell death or dysfunction. Another proposed mechanism is the degradation of specific proteins involved in metabolism that reduce the functioning of pathways that regulate heart muscle contraction. The present study identified a new mechanism, namely NAD+ depletion, that leads to heart muscle cell dysfunction in the context of autophagy.
Using a mouse model with autophagy dysfunction in heart cells, the research team found that autophagy regulates the enzyme NNMT, whose levels were increased in this heart failure model. Inhibiting the activity of this enzyme with a small molecule led to an improvement in heart failure even though autophagy failure persisted.
The study elucidated a chain event that explains how and why impaired autophagy can lead to cardiac dysfunction. The first step of this chain is the accumulation of a protein known as SQSTM1. Increased SQSTM1 activates a signaling protein called NF-κB (also known as RELA). NF-κB enters the nucleus and causes increased activity of the gene that encodes the enzyme known as nicotinamide N-methyltransferase (NNMT). NNMT ultimately leads to a breakdown of NAD+ precursors, ultimately lowering NAD+ levels. Low NAD+ levels then cause mitochondrial and cardiac dysfunction.
Unraveling this pathway has linked NAD+ metabolism and autophagy. These findings indicate a new potential therapy for reversing mitochondrial dysfunction and improving heart failure through preventing NAD+ loss and boosting its level in cardiac muscle.
https://www.embopress.org/doi/full/10.1038/s44318-023-00009-w
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fcontrol-of-nad&filter=22
New connection between impaired autophagy and heart failure
- 693 views
- Added
Latest News
Liver biopsy to predict pan…
By newseditor
Posted 03 Jul
Significant differences in…
By newseditor
Posted 02 Jul
Serotonin 2C receptor regul…
By newseditor
Posted 02 Jul
First TB specific PET scan
By newseditor
Posted 02 Jul
Molecular mechanisms of som…
By newseditor
Posted 01 Jul
Other Top Stories
Role of gut bacteria in neurogenesis and aging!
Read more
Genetic screening of malaria parasite depicts metabolic vulnerability
Read more
Colorectal cancer epigenetic signatures is linked to microbiota
Read more
A transcription factor modulates antibody maturation in response to…
Read more
A new antibiotic selectively kills drug-resistant gram negative bac…
Read more
Protocols
Monitoring norepinephrine r…
By newseditor
Posted 01 Jul
BicemuS: A new tool for neu…
By newseditor
Posted 26 Jun
Deciphering spatial domains…
By newseditor
Posted 23 Jun
High-throughput volumetric…
By newseditor
Posted 21 Jun
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Publications
Propionic acid promotes neu…
By newseditor
Posted 03 Jul
Association of genetic risk…
By newseditor
Posted 03 Jul
Emerging treatments in HER2…
By newseditor
Posted 02 Jul
Neuroimaging epicenters as…
By newseditor
Posted 02 Jul
Divergent landscapes of A-t…
By newseditor
Posted 02 Jul
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar